Notify me when Aptus Capital Advisors, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 1,564 | $10,953,319,783 | +$927,852,759 | -$651,171,822 | +$276,680,937 | ACIO, DRSK, NVDA, AAPL, MSFT | 13F-HR | 12 Nov 2025, 16:33 |
| Q2 2025 | 1,519 | $10,122,618,299 | +$1,306,213,709 | -$603,759,562 | +$702,454,147 | ACIO, DRSK, NVDA, MSFT, AAPL | 13F-HR | 11 Aug 2025, 10:25 |
| Q1 2025 | 1,431 | $8,822,347,766 | +$1,130,422,543 | -$521,886,541 | +$608,536,002 | ACIO, DRSK, AAPL, MSFT, NVDA | 13F-HR | 13 May 2025, 16:43 |
| Q4 2024 | 1,402 | $8,401,546,146 | +$2,119,261,356 | -$402,831,925 | +$1,716,429,431 | ACIO, DRSK, AAPL, MSFT, NVDA | 13F-HR | 14 Feb 2025, 16:22 |
| Q3 2024 | 1,231 | $6,527,871,521 | +$1,216,162,961 | -$167,335,915 | +$1,048,827,046 | ACIO, DRSK, AAPL, OSCV, MSFT | 13F-HR | 05 Nov 2024, 16:33 |
| Q2 2024 | 1,159 | $5,230,832,612 | +$872,670,368 | -$252,797,778 | +$619,872,590 | ACIO, DRSK, MSFT, OSCV, AAPL | 13F-HR | 31 Jul 2024, 16:55 |
| Q1 2024 | 1,157 | $4,656,862,397 | +$1,183,079,530 | -$138,692,400 | +$1,044,387,130 | ACIO, DRSK, OSCV, JUCY, MSFT | 13F-HR | 15 May 2024, 16:22 |
| Q4 2023 | 915 | $3,656,999,271 | +$202,682,714 | -$548,078,067 | -$345,395,353 | ACIO, DRSK, OSCV, AAPL, MSFT | 13F-HR | 13 Feb 2024, 14:58 |
| Q3 2023 | 935 | $3,671,021,741 | +$746,869,757 | -$1,112,376,321 | -$365,506,564 | ACIO, DRSK, TLT, OSCV, AAPL | 13F-HR | 08 Nov 2023, 14:33 |
| Q2 2023 | 792 | $4,170,034,368 | +$972,656,653 | -$373,386,880 | +$599,269,773 | ACIO, DRSK, TLT, OSCV, SO | 13F-HR | 11 Aug 2023, 10:13 |
| Q1 2023 | 786 | $3,722,418,292 | +$683,312,588 | -$257,128,194 | +$426,184,394 | DRSK, ACIO, DDOG, ADME, OSCV | 13F-HR | 09 May 2023, 15:19 |
| Q4 2022 | 793 | $3,257,386,447 | +$569,865,306 | -$686,921,580 | -$117,056,274 | DRSK, ACIO, DDOG, IBDS, ADME | 13F-HR | 13 Feb 2023, 15:13 |
| Q3 2022 | 749 | $4,151,281,040 | +$1,368,536,967 | -$228,969,429 | +$1,139,567,538 | LQD, TLT, DRSK, ACIO, ADME | 13F-HR | 02 Nov 2022, 11:49 |
| Q2 2022 | 644 | $3,836,745,092 | +$1,694,766,872 | -$241,335,597 | +$1,453,431,275 | DRSK, EFA, LOW, ACIO, IBDS | 13F-HR | 29 Jul 2022, 14:54 |
| Q1 2022 | 659 | $4,003,255,152 | +$1,275,098,070 | -$57,689,413 | +$1,217,408,657 | DRSK, FIS, IBDQ, IBDO, IBDR | 13F-HR | 04 May 2022, 12:36 |
| Q4 2021 | 543 | $3,330,428,257 | +$743,625,413 | -$58,862,060 | +$684,763,353 | DRSK, IBDO, IBDQ, IBDP, ACIO | 13F-HR | 02 Feb 2022, 14:03 |
| Q3 2021 | 515 | $2,533,007,000 | +$535,735,420 | -$175,517,277 | +$360,218,143 | DRSK, IBDO, IBDN, IBDP, ACIO | 13F-HR | 27 Oct 2021, 16:33 |
| Q2 2021 | 539 | $2,195,517,000 | +$247,378,366 | -$46,310,766 | +$201,067,600 | DRSK, IBDO, ADME, ACIO, IBDN | 13F-HR | 27 Jul 2021, 13:18 |
| Q1 2021 | 487 | $1,915,214,000 | +$284,456,046 | -$105,952,584 | +$178,503,462 | DRSK, IBDO, ACIO, ADME, IBDN | 13F-HR | 06 May 2021, 14:38 |
| Q4 2020 | 452 | $2,166,340,000 | +$613,225,509 | -$57,391,156 | +$555,834,353 | DRSK, ADME, ACIO, IBDO, IBDN | 13F-HR | 10 Feb 2021, 14:12 |
| Q3 2020 | 454 | $1,881,894,023 | +$602,509,401 | -$179,864,197 | +$422,645,204 | DRSK, ADME, ACIO, QQQ, LQD | 13F-HR | 16 Oct 2020, 17:40 |
| Q2 2020 | 401 | $1,591,841,000 | +$554,876,985 | -$79,308,774 | +$475,568,211 | DRSK, ACIO, ADME, SPY, IBDO | 13F-HR | 22 Jul 2020, 10:21 |
| Q1 2020 | 393 | $1,155,601,000 | +$369,884,391 | -$144,319,889 | +$225,564,502 | DRSK, ACIO, ADME, BSCK, QQQ | 13F-HR | 07 May 2020, 10:40 |
| Q4 2019 | 490 | $1,410,227,024 | +$541,914,761 | -$702,079,825 | -$160,165,064 | DRSK, QQQ, ACIO, ADME, SPY | 13F-HR | 10 Feb 2020, 12:53 |
| Q3 2019 | 466 | $1,790,008,000 | +$1,194,092,790 | -$80,065,742 | +$1,114,027,048 | SPY, DRSK, ACIO, FTVA, ADME | Restatement | 14 Nov 2019, 16:15 |
| Q2 2019 | 325 | $708,930,000 | +$169,559,072 | -$24,228,838 | +$145,330,234 | DRSK, FTVA, ADME, OSCV, SPDW | 13F-HR | 12 Aug 2019, 17:55 |
| Q1 2019 | 302 | $582,570,000 | +$307,170,879 | -$14,810,406 | +$292,360,473 | DRSK, FTVA, ADME, OSCV, IBDR | 13F-HR | 15 May 2019, 16:18 |
| Q4 2018 | 171 | $378,290,000 | $0 | DRSK, IEF, FTVA, SHY, SPLG | 13F-HR | 12 Feb 2019, 14:07 |